SlideShare a Scribd company logo
1 of 12
Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
Value to the
Strategic Partner
Healthcare’s Investment Bank
2015: Global Healthcare Capital Markets
S T R A T E G I C P A R T N E R I N G P A T H W A Y
Healthcare’s Investment Bank
HealthiosXchange for Strategic Partners
PHASE 1:
Sector
Development
PHASE 2:
Positioning
PHASE 3:
Engagement
PHASE 5:
Growth
PHASE 4:
Relationship
PHASE 4:
Data
Analytics
S T R A T E G I C P A R T N E R I N G P A T H W A Y
Healthcare’s Investment Bank
PHASE 1:
Sector
Development
Selecting Sectors. Assembling EcoSystems. Aggregating Content.
PHASE 2:
Positioning
Establishing Thought Leadership, Strategic Priorities & Process
PHASE 3:
Engagement
Building Dialogue with Broad Universe of Targets
PHASE 4:
Relationship
Solidifying Commitments with Priority Opportunities
PHASE 4:
BIG
Data
Trending. Predictions. Sentiment Analysis. Opinion Marking.
PHASE 5:
Growth
Taking Action.
HealthiosXchange for Strategic Partners
Healthcare’s Investment Bank
HealthiosXchange for Strategic Partners
PHASE 1:
Sector
Development
Selection &
Segmentation
Assembling
EcoSystems
Company
Listings
Presentations &
O/M
Clinical /
Market Data
Tagging
PHASE 2:
Positioning
Strategic Page
Communities &
Groups
Clinical &
Market Research
Sector Pages
Xchange
“LifeLines”
Integrated Social
Media
PHASE 3:
Engagement
Custom Content
Notifications
Private / Public
Valuations
“Xchange Live”
Hosted Chat
Ratings &
Reviews
Expert Opinion
WebCasts
PHASE 5:
Growth
Opportunity
Origination
Site Visits
Due Diligence
LOI
PHASE 4:
Relationship
Targeting &
Tracking
Messaging &
Alerts
“Grand Rounds”
WebCast
“Shark Tank”
Xchange
Conferences
PHASE 4:
BIG
Data
18 million Data
Points
3,000 Concurrent
Experiments
Trending &
Activity Scores
Milestones &
Inflection Points
Sentiment &
Prediction
Healthcare’s Investment Bank
PHASE 1: Sector Development
Segmentation &
Selection
Assembling
EcoSystems
Company
Listings
Presentations &
O/M
Clinical /
Market Data
Tagging
Healthcare’s Investment Bank
PHASE 2: Positioning
Strategic Page
Communities &
Groups
Clinical &
Market Research
Sector Pages
Xchange
“LifeLines”
Integrated Social
Media
Healthcare’s Investment Bank
Phase 3: Engagement
Custom Content
Notifications
Private / Public
Valuations
Matching &
GeoLocation
Ratings &
Reviews
WebCasts &
Chat
Healthcare’s Investment Bank
Phase 4: Relationships
Targeting &
Tracking
Messaging &
Alerts
“Grand Rounds”
WebCast
“Shark Tank”
Xchange
Conferences
Healthcare’s Investment Bank
Phase 5: BIG Data
Merger and acquisition
prediction. Note that
confidence is a bit smaller
than 1.
The actual
number of
months before
the next
transaction is 4.
We predicted 3.
The actual number
of months before
the next
transaction is 11.
We predicted 10.
The actual value of the next
transaction is $150 million
and we predicted $150
million.
The actual value of the next transaction is $21.65
million and we predicted $21.65 million.
Target/Issuer
Noveko
International Inc.
Sector Diagnostic Imaging
State Quebec
Country Canada
T1_Type Private Placement
T1_Total_Value 2.41
Months from T1 and T2 13
T2_Type Private Placement
T2_Total_Value 2.68
Months from T2 and T3 8
T3_Type Private Placement
T3_Total_Value 1.89
Next Transaction value
(ORIGINAL)
21.65
Next Transaction value
(PREDICTED)
21.65
Prediction confidence 0.9106
Type of event?
When is it going to happen?
How big will it be?18 million Data
Points
3,000 Concurrent
Experiments
Trending &
Activity Scores
Milestones &
Inflection Points
Sentiment &
Prediction
Healthcare’s Investment Bank
Phase 6: Growth
Opportunity
Origination
Site Visits
Due Diligence
LOI
$259,000,000
Completed a strategic partnership with
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO INSPIRATION
INSPIRATION
BIOPHARMACEUTICALS, INC.
Healthcare’s Investment Bank
HealthiosXchange for Strategic Partners
PHASE 1:
Sector
Development
Company
Profile
Selection &
Segmentation
Assembling
EcoSystems
Company
Listings
Presentations &
O/M
Clinical /
Market Data
Tagging
PHASE 2:
Positioning
Strategic
Profile
Strategic Page
Communities &
Groups
Clinical &
Market Research
Sector Pages
Xchange
Timeline
Integrated Social
Media
PHASE 3:
Engagement
Going
Social
Xchange
“LifeLines”
Notifications
Private / Public
Valuations
“Xchange Live”
Hosted Chat
Ratings &
Reviews
Expert Opinion
WebCasts
PHASE 5:
Growth
Close
Deal Selection
Site Visits
Due Diligence
LOI
PHASE 4:
Relationship
Deal
Selection
Targeting &
Tracking
Messaging &
Alerts
“Grand Rounds”
WebCast
“Shark Tank”
Xchange
Conferences
PHASE 4:
Data
Analytics
Taking
Action
18 million Data
Points
3,000 Concurrent
Experiments
Trending &
Activity Scores
Milestones &
Inflection Points
Sentiment &
Prediction

More Related Content

Viewers also liked

Cheetah Technologies
Cheetah TechnologiesCheetah Technologies
Cheetah TechnologiesRob
 
геоинформационная система
геоинформационная системагеоинформационная система
геоинформационная системаgueste0c7dc
 
Sushislide
SushislideSushislide
Sushislides1170017
 
Value to direct investor
Value to   direct investorValue to   direct investor
Value to direct investorScott jordan
 
Transforming capital markets
Transforming capital marketsTransforming capital markets
Transforming capital marketsScott jordan
 
Jennifer T. Liab Project
Jennifer T. Liab ProjectJennifer T. Liab Project
Jennifer T. Liab ProjectJennifer
 
Value to emerging growth companies
Value to  emerging growth companiesValue to  emerging growth companies
Value to emerging growth companiesScott jordan
 
OWASP Logging Project - Presentation at IBWAS09
OWASP Logging Project - Presentation at IBWAS09OWASP Logging Project - Presentation at IBWAS09
OWASP Logging Project - Presentation at IBWAS09MarcChisinevski
 
غرائب وعجائب الصور
غرائب وعجائب الصورغرائب وعجائب الصور
غرائب وعجائب الصورmoath Al-Baltan
 
حماية الأطفال من الإعتداء الجنسي
حماية الأطفال من الإعتداء الجنسيحماية الأطفال من الإعتداء الجنسي
حماية الأطفال من الإعتداء الجنسيmoath Al-Baltan
 

Viewers also liked (13)

Trabajo De Cal
Trabajo De CalTrabajo De Cal
Trabajo De Cal
 
Cheetah Technologies
Cheetah TechnologiesCheetah Technologies
Cheetah Technologies
 
геоинформационная система
геоинформационная системагеоинформационная система
геоинформационная система
 
Sushislide
SushislideSushislide
Sushislide
 
Value to direct investor
Value to   direct investorValue to   direct investor
Value to direct investor
 
Transforming capital markets
Transforming capital marketsTransforming capital markets
Transforming capital markets
 
Jennifer T. Liab Project
Jennifer T. Liab ProjectJennifer T. Liab Project
Jennifer T. Liab Project
 
Value to emerging growth companies
Value to  emerging growth companiesValue to  emerging growth companies
Value to emerging growth companies
 
OWASP Logging Project - Presentation at IBWAS09
OWASP Logging Project - Presentation at IBWAS09OWASP Logging Project - Presentation at IBWAS09
OWASP Logging Project - Presentation at IBWAS09
 
12. formulir ssp
12. formulir ssp12. formulir ssp
12. formulir ssp
 
غرائب وعجائب الصور
غرائب وعجائب الصورغرائب وعجائب الصور
غرائب وعجائب الصور
 
الحارس
الحارسالحارس
الحارس
 
حماية الأطفال من الإعتداء الجنسي
حماية الأطفال من الإعتداء الجنسيحماية الأطفال من الإعتداء الجنسي
حماية الأطفال من الإعتداء الجنسي
 

Similar to Value to strategic partners

Transforming Health Care In Africa
Transforming Health Care In Africa Transforming Health Care In Africa
Transforming Health Care In Africa Jacques Kpodonu,MD
 
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation ConferenceDay 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation ConferenceCanadian Organization for Rare Disorders
 
Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...Len Starnes
 
IVD Market Size and Growth Trend
IVD Market Size and Growth TrendIVD Market Size and Growth Trend
IVD Market Size and Growth TrendBruce Carlson
 
Big Data and Analytic Strategy for Clinical Research
Big Data and Analytic Strategy for Clinical ResearchBig Data and Analytic Strategy for Clinical Research
Big Data and Analytic Strategy for Clinical ResearchBBCR Consulting
 
Cytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocpCytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocpcytoriIR
 
Information Systems to support the management of patients with Chronic Condit...
Information Systems to support the management of patients with Chronic Condit...Information Systems to support the management of patients with Chronic Condit...
Information Systems to support the management of patients with Chronic Condit...Health Informatics New Zealand
 
디지털 헬스케어 글로벌 동향: 2017년 상반기
디지털 헬스케어 글로벌 동향: 2017년 상반기디지털 헬스케어 글로벌 동향: 2017년 상반기
디지털 헬스케어 글로벌 동향: 2017년 상반기Yoon Sup Choi
 
Cytori corp feb 10 2016 final
Cytori corp feb 10 2016 finalCytori corp feb 10 2016 final
Cytori corp feb 10 2016 finalcytoriIR
 
Cytori corp feb 2016 final
Cytori corp feb 2016 finalCytori corp feb 2016 final
Cytori corp feb 2016 finalcytoriIR
 
Top 4 global trends in life science and healthcare and why is this important ...
Top 4 global trends in life science and healthcare and why is this important ...Top 4 global trends in life science and healthcare and why is this important ...
Top 4 global trends in life science and healthcare and why is this important ...STELIOS PIGADIOTIS
 
Leukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to InnovationLeukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to InnovationTRAIN Central Station
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachDebra A. Chanda
 
KFSHRC_Annual-Research-Report2015
KFSHRC_Annual-Research-Report2015KFSHRC_Annual-Research-Report2015
KFSHRC_Annual-Research-Report2015Mansoor Baig
 
Nanotechnology in Healthcare Sector - A Perspective of Biosensors
Nanotechnology in Healthcare Sector - A Perspective of BiosensorsNanotechnology in Healthcare Sector - A Perspective of Biosensors
Nanotechnology in Healthcare Sector - A Perspective of BiosensorsYang FENG
 
Cabot Wealth Management's Roadmap to Retirement
Cabot Wealth Management's Roadmap to RetirementCabot Wealth Management's Roadmap to Retirement
Cabot Wealth Management's Roadmap to RetirementCabot Wealth Management
 

Similar to Value to strategic partners (20)

Transforming Health Care In Africa
Transforming Health Care In Africa Transforming Health Care In Africa
Transforming Health Care In Africa
 
1 6 managing healthcare diversity
1 6 managing healthcare diversity1 6 managing healthcare diversity
1 6 managing healthcare diversity
 
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation ConferenceDay 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
 
Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...Will global HCPs networks become communities of choice for rare-disease speci...
Will global HCPs networks become communities of choice for rare-disease speci...
 
IVD Market Size and Growth Trend
IVD Market Size and Growth TrendIVD Market Size and Growth Trend
IVD Market Size and Growth Trend
 
Big Data and Analytic Strategy for Clinical Research
Big Data and Analytic Strategy for Clinical ResearchBig Data and Analytic Strategy for Clinical Research
Big Data and Analytic Strategy for Clinical Research
 
Cytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocpCytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocp
 
Information Systems to support the management of patients with Chronic Condit...
Information Systems to support the management of patients with Chronic Condit...Information Systems to support the management of patients with Chronic Condit...
Information Systems to support the management of patients with Chronic Condit...
 
디지털 헬스케어 글로벌 동향: 2017년 상반기
디지털 헬스케어 글로벌 동향: 2017년 상반기디지털 헬스케어 글로벌 동향: 2017년 상반기
디지털 헬스케어 글로벌 동향: 2017년 상반기
 
Cytori corp feb 10 2016 final
Cytori corp feb 10 2016 finalCytori corp feb 10 2016 final
Cytori corp feb 10 2016 final
 
Cytori corp feb 2016 final
Cytori corp feb 2016 finalCytori corp feb 2016 final
Cytori corp feb 2016 final
 
Investor Present 04202017
Investor Present  04202017Investor Present  04202017
Investor Present 04202017
 
Top 4 global trends in life science and healthcare and why is this important ...
Top 4 global trends in life science and healthcare and why is this important ...Top 4 global trends in life science and healthcare and why is this important ...
Top 4 global trends in life science and healthcare and why is this important ...
 
Leukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to InnovationLeukemia Lymphoma Society: An Invitation to Innovation
Leukemia Lymphoma Society: An Invitation to Innovation
 
2012 MHCC Web Presentation Proposal-Feb 2
2012 MHCC Web Presentation Proposal-Feb 22012 MHCC Web Presentation Proposal-Feb 2
2012 MHCC Web Presentation Proposal-Feb 2
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science Coach
 
KFSHRC_Annual-Research-Report2015
KFSHRC_Annual-Research-Report2015KFSHRC_Annual-Research-Report2015
KFSHRC_Annual-Research-Report2015
 
Nanotechnology in Healthcare Sector - A Perspective of Biosensors
Nanotechnology in Healthcare Sector - A Perspective of BiosensorsNanotechnology in Healthcare Sector - A Perspective of Biosensors
Nanotechnology in Healthcare Sector - A Perspective of Biosensors
 
Cabot Wealth Management's Roadmap to Retirement
Cabot Wealth Management's Roadmap to RetirementCabot Wealth Management's Roadmap to Retirement
Cabot Wealth Management's Roadmap to Retirement
 
Curing Cancer. In the Clouds. The Final Frontier.
Curing Cancer. In the Clouds. The Final Frontier.Curing Cancer. In the Clouds. The Final Frontier.
Curing Cancer. In the Clouds. The Final Frontier.
 

Value to strategic partners

  • 1. Diabetic Nephropathy Diabetic Retinopathy Hypercholesterolemia Oral Mucositis Gout Acute Lymphocytic Leukemia Bone Metastasis Brain Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Endometrial Cancer Ewing Sarcoma Gastric Cancer Gastrointestinal Stromal Tumors Head And Neck Cancer Hodgkin Lymphoma Kidney Cancer Liver Cancer Malignant Mesothelioma Medullary Thyroid Cancer Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Testicular Cancer Thyroid Cancer Age Related Macular Degeneration Keratoconjunctivitis sicca (Dry Eye) Retinal Vein Occlusion Acute Respiratory Distress Syndrome Sepsis Staphylococcal Infections Acute Coronary Syndrome Angina Pectoris Atrial Fibrillation Coronary Artery Disease (CAD) Critical Limb Ischemia Hypertension Pulmonary Arterial Hypertension Acute Pain Anxiety Disorders Chronic Pain Dementia Diabetic Neuropathy Obsessive-Compulsive Disorder Osteoarthritis Pain Parkinson's Disease Post-Traumatic Stress Disorder Restless Legs Syndrome Schizophrenia Traumatic Brain Injury Liver Cirrhosis Childhood Enuresis Growth Hormone Disorders Hyperparathyroidism Hyperthyroidism Guillain-Barre Syndrome Cytomegalovirus Fungal Infections Gram-Negative Bacterial Infections H1N1 Infection Herpes Zoster HIV-1 Infection Human Papillomavirus Infections Staphylococcus Aureus (MRSA) Cardiovascular Devices Prosthetic Heart Valve Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices Cardiovascular Surgery Cardiac Rhythm Management Cardiovascular Prosthetic Devices Interventional Cardiology Cardiac Assist Devices Wound Care Management Hospital Supplies Syringes and Needles Disposable Hospital & Surgical Supplies Drug Delivery Devices Inhalation Systems Needle Free Injections Infusion Systems Diabetes Care Devices Insulin Delivery & Glucose Monitoring Ophthalmic Devices Cataract Surgery Devices Ophthalmic Diagnostic Equipment Refractive Surgery Devices ENT Devices Hearing Implants Diagnostic Devices Electrosurgical Devices Dental Equipment & Accessories Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment X-Ray & Ultrasound Systems Nuclear Imaging Equipment Contrast Media Injectors Bone Densitometry Anesthesia and Respiratory Devices Anesthesia Machines & Disposables Respiratory Devices & Disposables Sleep Apnea Diagnostic Systems Healthcare IT Medical Imaging Information Systems Nephrology and Urology Devices Renal Dialysis Equipment Orthopedic Devices Orthobiologics & Arthroscopy Joint Reconstruction Trauma Fixation Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF) Spinal Surgery Endoscopy Devices & instruments Rigid & Flexible Endoscope In Vitro Diagnostics Genetic Testing Clinical Chemistry Hematology Immuno Chemistry Infectious Immunology Histology And Cytology Patient Monitoring Multiparameter Patient Monitoring Micro-Electromechanical Systems Non-invasive Blood Pressure Monitors Neurology Devices Neurostimulation Devices Interventional Neurology CSF Management Neurosurgical Products Radiosurgery Value to the Strategic Partner
  • 2. Healthcare’s Investment Bank 2015: Global Healthcare Capital Markets S T R A T E G I C P A R T N E R I N G P A T H W A Y
  • 3. Healthcare’s Investment Bank HealthiosXchange for Strategic Partners PHASE 1: Sector Development PHASE 2: Positioning PHASE 3: Engagement PHASE 5: Growth PHASE 4: Relationship PHASE 4: Data Analytics S T R A T E G I C P A R T N E R I N G P A T H W A Y
  • 4. Healthcare’s Investment Bank PHASE 1: Sector Development Selecting Sectors. Assembling EcoSystems. Aggregating Content. PHASE 2: Positioning Establishing Thought Leadership, Strategic Priorities & Process PHASE 3: Engagement Building Dialogue with Broad Universe of Targets PHASE 4: Relationship Solidifying Commitments with Priority Opportunities PHASE 4: BIG Data Trending. Predictions. Sentiment Analysis. Opinion Marking. PHASE 5: Growth Taking Action. HealthiosXchange for Strategic Partners
  • 5. Healthcare’s Investment Bank HealthiosXchange for Strategic Partners PHASE 1: Sector Development Selection & Segmentation Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging PHASE 2: Positioning Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange “LifeLines” Integrated Social Media PHASE 3: Engagement Custom Content Notifications Private / Public Valuations “Xchange Live” Hosted Chat Ratings & Reviews Expert Opinion WebCasts PHASE 5: Growth Opportunity Origination Site Visits Due Diligence LOI PHASE 4: Relationship Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences PHASE 4: BIG Data 18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction
  • 6. Healthcare’s Investment Bank PHASE 1: Sector Development Segmentation & Selection Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging
  • 7. Healthcare’s Investment Bank PHASE 2: Positioning Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange “LifeLines” Integrated Social Media
  • 8. Healthcare’s Investment Bank Phase 3: Engagement Custom Content Notifications Private / Public Valuations Matching & GeoLocation Ratings & Reviews WebCasts & Chat
  • 9. Healthcare’s Investment Bank Phase 4: Relationships Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences
  • 10. Healthcare’s Investment Bank Phase 5: BIG Data Merger and acquisition prediction. Note that confidence is a bit smaller than 1. The actual number of months before the next transaction is 4. We predicted 3. The actual number of months before the next transaction is 11. We predicted 10. The actual value of the next transaction is $150 million and we predicted $150 million. The actual value of the next transaction is $21.65 million and we predicted $21.65 million. Target/Issuer Noveko International Inc. Sector Diagnostic Imaging State Quebec Country Canada T1_Type Private Placement T1_Total_Value 2.41 Months from T1 and T2 13 T2_Type Private Placement T2_Total_Value 2.68 Months from T2 and T3 8 T3_Type Private Placement T3_Total_Value 1.89 Next Transaction value (ORIGINAL) 21.65 Next Transaction value (PREDICTED) 21.65 Prediction confidence 0.9106 Type of event? When is it going to happen? How big will it be?18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction
  • 11. Healthcare’s Investment Bank Phase 6: Growth Opportunity Origination Site Visits Due Diligence LOI $259,000,000 Completed a strategic partnership with THE UNDERSIGNED ACTED AS EXCLUSIVE FINANCIAL ADVISOR TO INSPIRATION INSPIRATION BIOPHARMACEUTICALS, INC.
  • 12. Healthcare’s Investment Bank HealthiosXchange for Strategic Partners PHASE 1: Sector Development Company Profile Selection & Segmentation Assembling EcoSystems Company Listings Presentations & O/M Clinical / Market Data Tagging PHASE 2: Positioning Strategic Profile Strategic Page Communities & Groups Clinical & Market Research Sector Pages Xchange Timeline Integrated Social Media PHASE 3: Engagement Going Social Xchange “LifeLines” Notifications Private / Public Valuations “Xchange Live” Hosted Chat Ratings & Reviews Expert Opinion WebCasts PHASE 5: Growth Close Deal Selection Site Visits Due Diligence LOI PHASE 4: Relationship Deal Selection Targeting & Tracking Messaging & Alerts “Grand Rounds” WebCast “Shark Tank” Xchange Conferences PHASE 4: Data Analytics Taking Action 18 million Data Points 3,000 Concurrent Experiments Trending & Activity Scores Milestones & Inflection Points Sentiment & Prediction

Editor's Notes

  1. Today – more than ever before – the global healthcare industry is governed by strategic activity. In fact, the long-term success of strategic buyers and healthcare investors, alike, is inextricably tied to mergers, acquisitions and partnerships. For years, the priorities of strategic buyers throughout the global healthcare industry have emphasized marketing, sales and distribution as the principal drivers of shareholder value. This emphasis has fostered an intense dependence on M&A in order to sustain growth. In fact, although the dependence of strategic buyers on M&A is only accelerating, the competition for the best assets is intensifying. The best deals are increasingly difficult to secure…
  2. In 2014, (2,017) M&A and partnering transactions were competed by 716 strategic partners. Since 2007, (2,052) strategic partners have consummated at least one transaction. HealthiosXchange understands that strategic activity is vital to vibrant, dynamic and efficient capital markets. In recognition of the importance of mergers, acquisitions and partnerships as the foundation of the global healthcare capital markets, the HealthiosXchange has been designed to assist the most important strategic partners in the world in achieving their own growth objectives and competitive priorities. For strategic partners, the HealthiosXchange is: The most dynamic business development experience serving the global healthcare industry A virtual expression of their distinct competitive advantages A data-centric platform which mimics the development and strategic pathway A highly efficient social medium involving all the market participants critical to success
  3. In 2014, 7 of the top 10 M&A deals were in healthcare HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. In positioning 2,000 strategic partners at the center of 6,000 emerging growth companies in (46) market sectors and (37) countries, HealthiosXchange has developed a revolutionary business development asset to support the competitive priorities of the most important strategic partners in the world.
  4. 92% of the market capitalization of the top 25 healthcare companies is trading at (or above) their all-time highs The HealthiosXchange for strategic partners involves a six-step routine, leveraging the most advanced technologies to permit access to data, relationships and opportunities in a infinitely scalable – yet completely customized – manner: SECTOR DEVELOPMENT: Developing an Xchange presence POSITIONING: Establishing Thought Leadership ENGAGEMENT: Shaping the message with a broad audience RELATIONSHIPS: Solidifying commitments with priority opportunities DATA ANALYTICS: Applying proprietary informatics to optimize decision-making GROWTH: Taking Action
  5. At 17.2x, the Price/Earnings ratio of the S&P Healthcare index is at its highest point since 2002 PHASE 1 allows every strategic sponsor to organize their unique HealthiosXchange experience: Sectors are selected according to market presence EcoSystems consisting of Emerging Growth companies, investors, and key relationships are assembled according sector preferences Listings are established for every Emerging Growth Company in a designated sector Non-confidential Company information is gathered into each Company profile, along with preference data to enable transactions EcoSystem participants are “tagged” in order to enable data analytics (e.g. activity mapping, trending, geolocation, matching, targeting, alerts, notifications, prediction and sentiment analytics)
  6. The 3-year organic revenue growth rate of the top-25 healthcare companies is 6.1% PHASE 2 enables strategic sponsors to establish a leadership presence within their selected market EcoSystems: Strategic sponsors will populate their own Xchange profile Xchange Groups will be assembled, containing members of sector EcoSystems designated for “Friending” and “Following” Research, opinion analysis, position papers will be posted to the Xchange which will inform the EcoSystems of priorities, perspectives and strategies of each strategic sponsor Sector Pages will assemble the Xchange listings of all EcoSystem participants Xchange “LifeLines” comprised real-time news feeds, customized by each Strategic sponsor, and targeted for each EcoSystem Each Xchange EcoSystem will be mapped to prevailing social medial networks
  7. The market’s own growth expectation – as implied by the forward-year P/E ratio – is 13.1% PHASE 3 empowers strategic sponsors to establish their “Voice” with a broad audience of EcoSystem participa: Xchange LifeLines provides a constant “news feed” for the distribution of custom content Notifications allows strategic sponsors to be informed on the achievement of milestones, inflection points and catalysts Data on public and private transactions in selected market EcoSystems enables informed dialogue with target companies Exclusive targeting capabilities allows strategic sponsors to prioritize conversations among companies Proprietary Ratings & Review capabilities provides the market sentiment on a universe of companies in selected EcoSystems Integrated broadcasting capabilities enable communications with a broad audience of companies in an anonymous fashion
  8. The number of strategic partnerships has increased 30% annually since 2010 PHASE 4 assists strategic sponsors in solidifying relationships with priority targets within a designated EcoSystem. The principal elements of Step #4 are Targeting and tracking specific transactions Secure messaging with management & Board “Grand Rounds” events, featuring many strategic sponsors hosting virtual conferences with many companies in a highly dynamic and efficient environment “Shark Tank” events, featuring one strategic sponsor presiding over a virtual presentation by many companies Live conference events (e.g. Incubator Days, Clinical Meetings, Investor Conferences) involving key participants from strategic sponsors and the management and Board of companies in selected sectors
  9. Since 2002, 100% of the returns realized from emerging growth healthcare investments were generated by 23.6% of Companies PHASE 5 provides strategic sponsors with real-time data to measure the success of the Xchange process, reporting on activity within designated EcoSystems, and disseminating performance scores of target opportunities: Continuous analytics on 18 million data-points emanating from the activities of (6,000) companies , (30,000) investors, and (2,000) strategic buyers throughout the global healthcare industry 3,000 concurrent data experiments generating proprietary insights in key market categories Real-time trending and activity scores Benchmarking of key milestones and inflection points against 25-year historical and precedent data Exclusive sentiment analysis and event prediction
  10. Since 2002, 100% of the returns realized from emerging growth healthcare investments were generated by 14.2% of the invested capital. PHASE 6 supports strategic sponsors in selecting opportunities, organizing the process and consummating the transaction.
  11. HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. In positioning 2,000 strategic partners at the center of 6,000 emerging growth companies in (46) market sectors and (37) countries, HealthiosXchange has developed a revolutionary business development asset to support the competitive priorities of the most important strategic partners in the world.